Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lymphadenopathy × isatuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other 1 Gastrointestinal 1

Conditions

Multiple Myeloma 2 Purpura 1 Nausea 1 Macroglossia 1 Lymphadenopathy 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatomegaly 1 Gastrointestinal Hemorrhage 1 Diarrhea 1 Constipation 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed

43 enrolled 23 charts

GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Data powered by HemOnc (CC BY 4.0) Colophon ⚡